According to Harvard Bioscience's latest financial reports the company's current earnings are A$87.37 Million. In 2024 the company made an earning of -A$17.66 Million a decrease over its 2023 earnings that were of -A$3.87 Million. The earnings displayed on this page is the company's Pretax Income.